Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Aging (Upcoming)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Cross-dressed dendritic cells sustain effector T cell responses in islet and kidney allografts
Andrew D. Hughes, … , Martin H. Oberbarnscheidt, Fadi G. Lakkis
Andrew D. Hughes, … , Martin H. Oberbarnscheidt, Fadi G. Lakkis
Published November 25, 2019
Citation Information: J Clin Invest. 2020;130(1):287-294. https://doi.org/10.1172/JCI125773.
View: Text | PDF
Research Article Immunology Transplantation

Cross-dressed dendritic cells sustain effector T cell responses in islet and kidney allografts

  • Text
  • PDF
Abstract

Activation of host T cells that mediate allograft rejection is a 2-step process. The first occurs in secondary lymphoid organs where T cells encounter alloantigens presented by host DCs and differentiate to effectors. Antigen presentation at these sites occurs principally via transfer of intact, donor MHC-peptide complexes from graft cells to host DCs (cross-dressing) or by uptake and processing of donor antigens into allopeptides bound to self-MHC molecules (indirect presentation). The second step takes place in the graft, where effector T cells reengage with host DCs before causing rejection. How host DCs present alloantigens to T cells in the graft is not known. Using mouse islet and kidney transplantation models, imaging cytometry, and 2-photon intravital microscopy, we demonstrate extensive cross-dressing of intragraft host DCs with donor MHC-peptide complexes that occurred early after transplantation, whereas host DCs presenting donor antigen via the indirect pathway were rare. Cross-dressed DCs stably engaged TCR-transgenic effector CD8+ T cells that recognized donor antigen and were sufficient for sustaining acute rejection. In the chronic kidney rejection model, cross-dressing declined over time but was still conspicuous 8 weeks after transplantation. We conclude that cross-dressing of host DCs with donor MHC molecules is a major antigen presentation pathway driving effector T cell responses within allografts.

Authors

Andrew D. Hughes, Daqiang Zhao, Hehua Dai, Khodor I. Abou-Daya, Roger Tieu, Rayan Rammal, Amanda L. Williams, Douglas P. Landsittel, Warren D. Shlomchik, Adrian E. Morelli, Martin H. Oberbarnscheidt, Fadi G. Lakkis

×

Figure 2

Cross-dressed host DCs make stable contacts with Ag-specific, CD8+ effector T cells in islet allografts.

Options: View larger image (or click on image) Download as PowerPoint
Cross-dressed host DCs make stable contacts with Ag-specific, CD8+ effec...
2P-IVM was performed on islet grafts 24 hours after transferring OT-I effectors as outlined in Figure 1A. Three mice were imaged per group with multiple locations (between 2 and 6) imaged per graft. (A) Equal infiltration of allografts with OT-I effectors (red) in all groups. Allografts were well vascularized (magenta) at the time of imaging and had abundant host-derived YFP+ DCs (green) in and around islets (blue). Supplemental Video 1, corresponding to the micrographs, illustrates dynamic behavior of OT-I in the grafts. Each data point in the plot represents total OT-I counts in 1 graft location imaged. Ctrl, control. (B) OT-I paths over 5-minute imaging period (blue dragon tails) and contact with DCs (white surfaces) are shown in the photomicrographs and in Supplemental Video 2. Quantification of OT-I DC contacts per image volume and contact time are shown in the graphs. Each data point in the first plot represents total OT-I DC contacts counts in 1 graft location imaged. Each data point in the second plot represents contact time for each OT-I cell (all cells that made contact with DCs for more than 90 seconds were analyzed per location imaged; range = 259–1450 cells/location). (C) Arrest of OT-I effectors in the cross-dressing group is depicted by the shorter paths they took compared with the indirect group (photomicrographs with paths tracked over a 30-minute period) and by the quantitation of mean speed and arrest coefficients (graphs). The arrest coefficient is the proportion of time in which a cell moves less than 2 μm/min. Each data point in the plots represents a single OT-I cell (all cells were analyzed per location imaged; range = 987–2361 cells/location). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Random intercept model with the Bonferroni’s multiple comparison adjustment for pairwise comparisons between group means was applied to avoid pseudoreplication errors. Comparisons not shown in Figure 2, B and C, were not significant. Scale bars: 50 μm (A); 40 μm (B); 100 μm (C).

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts